AZ SB1052

Authorizes assisted living homes and centers in Arizona to offer mild hyperbaric oxygen therapy to residents using FDA-cleared Class II chambers designed for home use that allow independent exit

Requires therapy to be provided only on a physician's order, with manufacturer-trained staff on-site during treatment sessions

Mandates written notice to residents that FDA approval covers only acute mountain sickness symptoms, with other uses considered off-label, and must include contraindication and risk information

Imposes additional requirements for residents needing directed care services, including a treating physician's order and informed consent from the resident or authorized representative

Grants the Arizona Department of Health Services authority to adopt rules implementing these provisions